daunorubicin has been researched along with Duncan Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camera, A; Chiurazzi, F; D'Arco, AM; Risitano, AM; Rossi, M; Rotoli, B | 1 |
| Bader, P; Boppana, S; Dormann, S; Fisch, P; Goebel, H; Jung, A; Kontny, U; Niemeyer, C; Peters, A; Strahm, B; Werner, M | 1 |
| Doria, G; Franchi, F; Konovalova, N; Pioli, C; Rossetti, R; Rossi Fanelli, F; Seminara, P; Tubani, L | 1 |
1 trial(s) available for daunorubicin and Duncan Disease
| Article | Year |
|---|---|
Activity of a nitroxylated analog of daunorubicin, ruboxyl, in B-lymphoproliferative disorders.
Topics: Aged; Aged, 80 and over; Animals; Antibiotics, Antineoplastic; B-Lymphocytes; Cells, Cultured; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Lymphocyte Count; Lymphoproliferative Disorders; Male; Mice; Mice, Inbred C57BL; Middle Aged; Multiple Myeloma; Pilot Projects; Remission Induction; Spleen; T-Lymphocytes; Waldenstrom Macroglobulinemia | 2001 |
2 other study(ies) available for daunorubicin and Duncan Disease
| Article | Year |
|---|---|
Acute lymphoblastic leukemia in the context of a disorder resembling X-linked lymphoproliferative (XLP) syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Burkitt Lymphoma; Carrier Proteins; Daunorubicin; Fatal Outcome; Genetic Heterogeneity; Granulocyte Colony-Stimulating Factor; Herpesvirus 4, Human; Humans; Infectious Mononucleosis; Intracellular Signaling Peptides and Proteins; Lamivudine; Lenograstim; Liver Failure; Lymphoproliferative Disorders; Male; Mucormycosis; Pleural Effusion; Prednisone; Recombinant Proteins; Signaling Lymphocytic Activation Molecule Associated Protein; Tumor Virus Infections; Vincristine | 2002 |
Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Cytarabine; Daunorubicin; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Glucocorticoids; Graft vs Host Disease; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Transfusion; Lymphoproliferative Disorders; Male; Postoperative Complications; Prednisolone; Rituximab; Time Factors; Transplantation Chimera; Transplantation Conditioning; Vincristine; Virus Activation; Whole-Body Irradiation | 2005 |